Trader Note — 8873 total
Amneal Pharmaceuticals enters the week with a fresh analyst upgrade pulling against a softening price, just fifteen days before its next earnings print. The most notable development is on the Street. UBS raised its…
Goosehead Insurance has reversed sharply since the prior note, shedding 9.5% on the week and 8.3% on Tuesday alone — yet short sellers have barely moved, and analysts are raising targets into the weakness. The pullback…
SPOT heads into its Q2 report on July 21 with short sellers retreating sharply and the Street trimming targets despite keeping bullish ratings — a setup that captures the tension between strong fundamental conviction…
Broadcom has slipped from $399.97 to $389.11 in the two sessions since Monday's report flagged the durability question — and the short sellers who built positions into last week's surge have not covered. The short…
VICI Properties enters its July 29 earnings report with one data point moving in its favour — short sellers are pulling back — while the analyst community keeps trimming targets, leaving the stock caught between…
Knight-Swift Transportation heads into its July 22 earnings release with short sellers rebuilding positions at speed, analysts raising targets in near-unison, and the Street debating whether a recovery already priced…
ROKU enters the final two weeks before its July 31 earnings report with a striking shift in the short book — and a Street that has already moved to the sidelines. The most important data point this week is not where…
Celcuity enters the back half of July with a striking divergence: analysts are raising price targets while a heavy short base refuses to budge, setting up a tug-of-war that the August 14 earnings date will likely…
ACHV enters the week carrying one of the sharpest short-building episodes in the small-cap biotech space, with bears accelerating positions even as the regulatory story becomes more constructive. Short interest has…
UroGen Pharma enters its August 10 earnings window with a notable shift in short positioning — bears have trimmed their exposure meaningfully this week, even as the stock consolidates near a month-long high. The short…
Vistra Corp. heads into its August 5 earnings date with analysts growing more constructive, options tilting toward calls, and short interest quietly unwinding from a June peak. The most notable move this week came from…
FB Financial Corporation delivered Q2 results on July 14 and the stock responded, yet the most interesting development this week is what happened in the options market after the print. The post-earnings move tells a…
International Seaways has added another 3.4% this week to close at $88.12, narrowing the gap to analyst targets with earnings now three weeks away. The stock's recent move means the gap between price and the consensus…
Smurfit WestRock heads into its July 29 earnings print with a widening gap between an emboldened analyst community and a stock that has lost nearly 5% on the week. The Street's move has been unusually decisive. Four…
Red Rock Resorts enters its August 3 earnings window with analysts growing more constructive just as short sellers quietly step back — a convergence that gives the setup an unusually clean bullish tilt heading into the…
Permian Resources heads into its August 3 earnings with the Street still bullish but quietly marking down expectations — and short sellers rebuilding positions at the fastest monthly pace in six months. The dominant…
SPCX has spent the past week locked in a standoff — analysts raising targets, shorts holding record positions, and the stock sliding further from both. The short base is the defining feature of this setup. Shares short…
Willis Towers Watson has pulled back off its recent highs, down 2.3% on Tuesday to $288.74, with short sellers adding pressure ahead of the July 30 Q2 report. Since the previous note flagged the 12.4% weekly surge, the…
Block, Inc. enters the final stretch before its August 5 earnings report with the short-side retreat that began in late June now accelerating into something more decisive — and a Street growing visibly more…
Axsome Therapeutics heads into its August 3 earnings print with the most significant development since last week's note being a sharp reversal in short positioning — a story that materially changes the setup described…
